stockrow
Monday 9 November 2026
Export SLBT’s income statement to Excel — free account
SL SCIENCE HLDG
SLBT
0.98
0.04
+4.26%
Follow SLBT
Alert me
SL SCIENCE HLDG (SLBT) Return on invested capital
SL SCIENCE HLDG's return on invested capital over the twelve months to 30 June 2026 was 0.00%. That is in line with the Biotechnology industry median of 0.00% and in line with the Healthcare sector median of 0.00%.
Return on invested capital, annual
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| PBYI Puma Biotechnology, Inc. compare | 42.6% |
| ENTX Entera Bio Ltd. compare | 0.00% |
| SLBT SL SCIENCE HLDG | 0.00% |
| FTH Faeth Therapeutics, Inc. compare | 0.00% |
| NGNE Neurogene Inc. compare | 0.00% |
| OVID Ovid Therapeutics compare | −35.1% |
| CLYM Climb Bio, Inc. compare | −71.7% |
| CAPR Capricor Therapeutics, Inc. compare | −1,019.7% |
| YDES YD Bio Limited compare | — |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)